(Q36689127)

15 August 2017

1 reference

title

Urachal carcinoma: surgical and chemotherapeutic options (English)

1 reference

15 August 2017

1 reference

Arlene Siefker-Radtke

series ordinal

1

1 reference

15 August 2017

publication date

1 December 2006

1 reference

Expert Review of Anticancer Therapy

15 August 2017

published in

1 reference

15 August 2017

volume

6

1 reference

15 August 2017

issue

12

1 reference

15 August 2017

page(s)

1715-1721

1 reference

Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1715

Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1715

Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1715

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1715

Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1715

Adenocarcinoma involving the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1715

Mucous adenocarcinoma of the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1715

Imaging findings of urachal mucinous cystadenocarcinoma associated with pseudomyxoma peritonei.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1715

Population based survival data on urachal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1715

Adenocarcinoma of urachus. Report of 7 cases and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1715

Phase III trial of fluorouracil, interferon alpha-2b, and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic or unresectable urothelial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1715

10.1586/14737140.6.12.1715

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference